XETRLIK
Market cap99mUSD
Dec 23, Last price
326.00EUR
1D
0.62%
1Q
-11.89%
IPO
218.73%
Name
Limes Schlosskliniken AG
Chart & Performance
P/E
28.14
P/S
2.57
EPS
11.58
Div Yield, %
0.00%
Shrs. gr., 5y
1.10%
Rev. gr., 5y
37.51%
Revenues
37m
+29.04%
Net income
3m
-19.20%
CFO
6m
-18.30%
Profile
LIMES Schlosskliniken AG operates private hospitals for psychiatry, psychotherapy, and psychosomatics services. It focuses on the treatment of stress-related illnesses, as well as mental and emotional disorders, such as depression, acute burnout, affective disorders, and trauma. The company is headquartered in Cologne, Germany. LIMES Schlosskliniken AG is a subsidiary of GMF Capital Gmbh.
IPO date
Mar 18, 2019
Employees
175
Domiciled in
DE
Incorporated in
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | 37,173 29.04% | 28,807 22.92% | 23,435 112.74% | ||||
Cost of revenue | 27,759 | 24,052 | 20,704 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 9,414 | 4,755 | 2,731 | ||||
NOPBT Margin | 25.33% | 16.51% | 11.65% | ||||
Operating Taxes | 676 | 743 | 197 | ||||
Tax Rate | 7.19% | 15.62% | 7.21% | ||||
NOPAT | 8,738 | 4,012 | 2,534 | ||||
Net income | 3,396 -19.20% | 4,203 6.57% | 3,944 -667.98% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | 4 | ||||||
Long-term debt | 10,090 | 9,038 | 4,334 | ||||
Deferred revenue | |||||||
Other long-term liabilities | 2,124 | 3,184 | 5,844 | ||||
Net debt | 1,571 | (1,888) | 1,850 | ||||
| Cash flow | |||||||
Cash from operating activities | 6,292 | 7,701 | 4,549 | ||||
CAPEX | (6,608) | (1,352) | (6,376) | ||||
Cash from investing activities | (9,788) | (1,310) | (6,376) | ||||
Cash from financing activities | 1,095 | 2,042 | 1,621 | ||||
FCF | 2,671 | 4,310 | 1,907 | ||||
| Balance | |||||||
Cash | 8,519 | 10,926 | 2,484 | ||||
Long term investments | |||||||
Excess cash | 6,660 | 9,485 | 1,313 | ||||
Stockholders' equity | 16,643 | 3,785 | 6,404 | ||||
Invested Capital | 22,197 | 19,633 | 15,175 | ||||
ROIC | 41.78% | 23.05% | 21.47% | ||||
ROCE | 32.62% | 20.30% | 16.56% | ||||
| EV | |||||||
Common stock shares outstanding | 293 | 293 | 293 | ||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | 12,061 | 7,410 | 4,216 | ||||
EV/EBITDA | |||||||
Interest | 392 | 224 | |||||
Interest/NOPBT | 8.24% | 8.21% | |||||